Recent studies showed that after overexpressing Pitx3 and being exposed to GDNF, NT2 cells could release DA, indicating that Pitx3-GDNF interactions in DA signaling may promote the dopaminergic neuronal properties of NT2 cells, making it clinically applicable for cell replacement therapy in PD [99]. The gene discussed is PITX3; the disease is Parkinson disease.